DRKS00027469
Completed
Not Applicable
Assessment of the role of the Xpert Bladder Cancer detect assay in patients with asymptomatic hematuria - Role of Xpert Detect Bladder Cancer assay in hamaturia
Cepheid Europe SAS0 sites400 target enrollmentJanuary 21, 2022
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- R31
- Sponsor
- Cepheid Europe SAS
- Enrollment
- 400
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •known bladder tumor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
BlaaskankerZorg In BeeldBladder cancerNL-OMON26633Dutch Cancer Society (KWF Kankerbestrijding)6,500
Completed
Not Applicable
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder CancerBladder CancerNCT03125460Cepheid424
Active, not recruiting
Not Applicable
rinary Xpert bladder cancer detection test in patients with haematuriaSuspected bladder cancerCancerMalignant neoplasm of bladderISRCTN40815027niversity of Dundee600
Recruiting
Not Applicable
Prospective Bladder Cancer Infrastructure - An infrastructure for observational and interventional bladder cancer researchbladder cancer10038364NL-OMON54621Stichting Prospectieve Blaaskanker Infrastructuur3,500
Completed
Not Applicable
A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)Non-muscle-invasive Bladder CancerNCT03664258Cepheid852